Device Trial Radar · NCT07719608
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Oct 1, 2028
Study completion May 1, 2031
Sponsor
- Lead sponsor
- Salvia BioElectronicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine.
Conditions
- Resistant Migraine
- Chronic Migraine Headache
- Headache (Migraine)
- Headache, Cluster
Interventions
NeurostimulatorDevice
A neurostimulation system that consists of implantable and non-implantable components that work together to deliver mild electrical signals to targeted craniofacial nerves.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Endpoint - EfficacyTime frame: 24 weeks
- Primary Outcome Measure - SafetyTime frame: 24 Weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Vista Clinical Research
Newnan, Georgia · Recruiting
MedStar Health Research Institute
Olney, Maryland · Recruiting
Queen City Clinical Research, PLLC
Charlotte, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.